BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastrointest Oncol 2015; 7(12): 422-433 [PMID: 26690833 DOI: 10.4251/wjgo.v7.i12.422]
URL: https://www.wjgnet.com/2308-3840/full/v7/i12/422.htm
Number Citing Articles
Callum G. Fraser. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challengesThe Surgeon 2018; 16(5): 302 doi: 10.1016/j.surge.2018.01.004
Cosmas Rinaldi Adithya Lesmana, Mutiara Lirendra, Laurentius Adrianto Lesmana. Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical PracticeAnnals of Colorectal Research 2019; (In Press) doi: 10.5812/acr.88488
Callum G. Fraser. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversiesGastroenterología y Hepatología 2019; 42(4): 263 doi: 10.1016/j.gastrohep.2018.09.007
Katarzyna Szymańska. Reference Module in Biomedical Sciences2018;  doi: 10.1016/B978-0-12-801238-3.65304-7
Zhendong Sha, Ting Hu, Yuanzhu Chen. Feature Selection for Polygenic Risk Scores using Genetic Algorithm and Network Science2021 IEEE Congress on Evolutionary Computation (CEC) 2021; : 802 doi: 10.1109/CEC45853.2021.9504993
Callum G. Fraser. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversiesGastroenterología y Hepatología (English Edition) 2019; 42(4): 263 doi: 10.1016/j.gastre.2019.03.003
Kieran Purich, Yiling Zhou, Shawn Dodd, Yan Yuan, Jonathan White. How can we better identify patients with rectal bleeding who are at high risk of colorectal cancer? An observational studyInternational Journal of Colorectal Disease 2021;  doi: 10.1007/s00384-021-04063-w
Joaquín Cubiella. Not so FAST. Commentary on the article “Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study”BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01322-y
Jayne Digby, Robert JC Steele, Judith A Strachan, Craig Mowat, Annie S Anderson, Rebecca McCann, Louise Law, Callum G Fraser. Do other variables add value to assessment of the risk of colorectal disease using faecal immunochemical tests for haemoglobin?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2019; 56(4): 472 doi: 10.1177/0004563219839423
Jayne Digby, Judith A. Strachan, Craig Mowat, Robert J. C. Steele, Callum G. Fraser. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational studyBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1135-5
Linas Kunigenas, Vaidotas Stankevicius, Audrius Dulskas, Elzbieta Budginaite, Gediminas Alzbutas, Eugenijus Stratilatovas, Nils Cordes, Kestutis Suziedelis. 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course TreatmentBiomolecules 2020; 10(4): 613 doi: 10.3390/biom10040613
Sally C Benton, Callum G Fraser. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration – can a repeat test be used?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2021; 58(3): 163 doi: 10.1177/0004563220967569
Jun Ma, Peilong Wang, Lei Huang, Jianxia Qiao, Jianhong Li. Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancerBMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-00905-2
Yuan Huang, Nannan Liu, Jing Liu, Yeying Liu, Chuchu Zhang, Shuaiyu Long, Guang Luo, Lingling Zhang, Yingjie Zhang. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMACell Cycle 2019; 18(24): 3442 doi: 10.1080/15384101.2019.1688951
María Gallardo-Gómez, Loretta De Chiara, Paula Álvarez-Chaver, Joaquin Cubiella. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based methodExpert Review of Anticancer Therapy 2021; 21(7): 723 doi: 10.1080/14737140.2021.1882858
Olusegun I. Alatise, Sara E. Fischer, Omobolaji O. Ayandipo, Akinlolu G. Omisore, Samuel A. Olatoke, T. Peter Kingham. Health-Seeking Behavior and Barriers to Care in Patients With Rectal Bleeding in NigeriaJournal of Global Oncology 2017; 3(6): 749 doi: 10.1200/JGO.2016.006601
Hossein Sadeghi, Ehsan Nazemalhosseini‐Mojarad, Unes Sahebi, Elnaz Fazeli, Ghasem Azizi‐Tabesh, Vahid R. Yassaee, Sanaz Savabkar, Hamid Asadzadeh Aghdaei, Mohammad R. Zali, Reza Mirfakhraie. Novel long noncoding RNAs upregulation may have synergistic effects on the  CYP24A1 and PFDN4 biomarker role in human colorectal cancer Journal of Cellular Physiology 2021; 236(3): 2051 doi: 10.1002/jcp.29992
Satoshi Nagayama, Siew-Kee Low, Kazuma Kiyotani, Yusuke Nakamura. Precision Medicine for Colorectal Cancer with Liquid Biopsy and ImmunotherapyCancers 2021; 13(19): 4803 doi: 10.3390/cancers13194803
J. A. Bailey, H. Ibrahim, J. Bunce, C. J. Chapman, J. R. Morling, J. A. Simpson, D. J. Humes, A. Banerjea. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer populationTechniques in Coloproctology 2021; 25(10): 1151 doi: 10.1007/s10151-021-02466-z
Pradeep S Virdee, Shona Kirtley, Leena Elhussein, Peter J Watkinson, Tim A Holt, Jacqueline Birks. Components of the full blood count as risk factors for colorectal cancer detection: a systematic review protocolBMJ Open 2019; 9(12): e032759 doi: 10.1136/bmjopen-2019-032759
Longyi Zhang, Yongjun Zhang, Chih-Hsin Tang, Chen-Ming Su. RAD52 gene polymorphisms are associated with risk of colorectal cancer in a Chinese Han populationMedicine 2017; 96(49): e8994 doi: 10.1097/MD.0000000000008994
Niels W. Schurink, Doenja M.J. Lambregts, Regina G.H. Beets-Tan. Diffusion-weighted imaging in rectal cancer: current applications and future perspectivesThe British Journal of Radiology 2019; 92(1096): 20180655 doi: 10.1259/bjr.20180655
Johan Tolstrup, Rasmus Chemnitz Madsen, Maria Vandborg Sneftrup, Birgit Niclasen. Greenlandic patients with colorectal cancer: symptomatology, primary investigations and differences in diagnostic intervals between Nuuk and the rest of the countryInternational Journal of Circumpolar Health 2017; 76(1): 1344086 doi: 10.1080/22423982.2017.1344086
Joshua C. Obuch, Dennis J. Ahnen. Colorectal CancerGastroenterology Clinics of North America 2016; 45(3): 459 doi: 10.1016/j.gtc.2016.04.005
Craig Mowat, Jayne Digby, Judith A Strachan, Rebecca K McCann, Francis A Carey, Callum G Fraser, Robert JC Steele. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary careAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2021; 58(3): 211 doi: 10.1177/0004563220985547
Nokuphila Winifred Nompumelelo Simelane, Cherie Ann Kruger, Heidi Abrahamse. Targeted Nanoparticle Photodynamic Diagnosis and Therapy of Colorectal CancerInternational Journal of Molecular Sciences 2021; 22(18): 9779 doi: 10.3390/ijms22189779
Jayne Digby, Shirley Cleary, Lynne Gray, Pooja Datt, David R Goudie, Robert J C Steele, Judith A Strachan, Adam Humphries, Callum G Fraser, Craig Mowat. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancerUnited European Gastroenterology Journal 2020; 8(5): 559 doi: 10.1177/2050640620913674
Marie Westwood, Shona Lang, Nigel Armstrong, Sietze van Turenhout, Joaquín Cubiella, Lisa Stirk, Isaac Corro Ramos, Marianne Luyendijk, Remziye Zaim, Jos Kleijnen, Callum G. Fraser. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidanceBMC Medicine 2017; 15(1) doi: 10.1186/s12916-017-0944-z
Marianne Regina Silva Potengy de MELLO, Silmara Fernandes MOURA, Camila Drumond MUZI, Raphael Mendonça GUIMARÃES. CLINICAL EVALUATION AND PATTERN OF SYMPTOMS IN COLORECTAL CANCER PATIENTSArquivos de Gastroenterologia 2020; 57(2): 131 doi: 10.1590/s0004-2803.202000000-24
Shirley H. F. Lee, Hanif Abdul Rahman, Nadiah Abidin, Sok King Ong, Elvynna Leong, Lin Naing. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002–09 and 2010–17BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08224-6
Yu Han, Yuan Qing Qu, Simon Wing Fai Mok, Juan Chen, Cheng Lai Xia, Hu Qiang He, Zheng Li, Wei Zhang, Cong Ling Qiu, Liang Liu, Betty Yuen Kwan Law, Vincent Kam Wai Wong. A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer CellsFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00912
Behnam Sanei, Fard Ghasemi, Mohsen Kolahduzan. The prevalence of low anterior resection syndrome in rectal cancer patients who underwent surgical treatment in Isfahan City Hospital during 2012-2018Medicinski casopis 2020; 54(1): 7 doi: 10.5937/mckg54-24636
Shalitha Sasi, Sapna Singh, Tamanna Walia, Ramesh Chand Meena, Suresh Thakur. Colon Cancer Diagnosis and Therapy2021; : 67 doi: 10.1007/978-3-030-63369-1_5
Hai Wang, Chengyan He, Zhaowei Yang, Shen Gao, Lingxia Li, Xiaoying Sun, Ling Fang, Ning Liu, Hongjun Li. Proteomics analysis of up-regulated NPM1 protein in colorectal cancerChemical Research in Chinese Universities 2016; 32(3): 402 doi: 10.1007/s40242-016-5519-6
Thaína Dalla Valle, Ruth Natalia Teresa Turrini, Vanessa de Brito Poveda. Intervening factors for the initiation of treatment of patients with stomach and colorectal cancerRevista Latino-Americana de Enfermagem 2017; 25(0) doi: 10.1590/1518-8345.1493.2879
Stephen T. McSorley, Jayne Digby, Danielle Clyde, Neil Cruickshank, Paul Burton, Louise Barker, Judith A. Strachan, Callum G. Fraser, Karen Smith, Craig Mowat, Jack Winter, Robert J.C. Steele. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary careColorectal Disease 2021; 23(7): 1615 doi: 10.1111/codi.15405
Ying-Chi Yang, Dong Wang, Lan Jin, Hong-Wei Yao, Jing-Hui Zhang, Jin Wang, Xiao-Mu Zhao, Chun-Ying Shen, Wei Chen, Xue-Liang Wang, Rong Shi, Si-Yi Chen, Zhong-Tao Zhang. Circulating tumor DNA detectable in early- and late-stage colorectal cancer patientsBioscience Reports 2018; 38(4) doi: 10.1042/BSR20180322
Ella Mozdiak, Yonas Weldeselassie, Michael McFarlane, Maria Tabuso, Monika M. Widlak, Amber Dunlop, Alexander Tsertsvadze, Ramesh P. Arasaradnam. Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier?Alimentary Pharmacology & Therapeutics 2019; 50(4): 348 doi: 10.1111/apt.15378
Tania Blackmore, Lynne Chepulis, Rawiri Keenan, Jacquie Kidd, Tim Stokes, David Weller, Jon Emery, Ross Lawrenson. How do colorectal cancer patients rate their GP: a mixed methods studyBMC Family Practice 2021; 22(1) doi: 10.1186/s12875-021-01427-7
Aaron J Quyn, Robert JC Steele, Jayne Digby, Judith A Strachan, Craig Mowat, Paula J McDonald, Francis A Carey, Ian M Godber, Hakim B Younes, Callum G Fraser. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: not FIT for purpose?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(1): 69 doi: 10.1177/0004563217707981
Marcela Ewing, Peter Naredi, Chenyang Zhang, Jörgen Månsson. Diagnostic profile characteristics of cancer patients with frequent consultations in primary care before diagnosis: a case-control studyFamily Practice 2018; 35(5): 559 doi: 10.1093/fampra/cmy012